Skip to main content
. 2017 Sep 8;18(10):775–782. doi: 10.1080/15384047.2017.1373212

Table 1.

Univariate overall survival analysis in patients with TP53 mutated status.

    Median OS p-value
  Clinical Characteristic Number of patients (CI 95%) Months (Log-Rank)
Age
 < = 70 years 159 32.80 (25.9 -NA) 4.90E-02
 >70 years 40 19.80 (17.1–53.9)
Gender
 Male 55 45.80 (28.0-NA) 9.40E-03
 Female 144 19.10 (14.8–42.4)
Tumor Stage
 I 6 26.4(21.8-NA) 6.16E-01
 II 35 47.90 (16.6-NA)
 III 53 53.9 (28.0-NA)
 IV 105 27.0 (18.5–45.8)
Tumor Site
 Larynx 62 30.90 (19.7-NA) 3.87E-01
 Oral cavity 127 42.40 (23.9-NA)
 Oropharynx 9 17.50 (15.1-NA)
Alcohol
 No 63 32.5 (19.1-NA) 7.85E-01
 Yes 131 30.9 (19.9-NA)
Smoking
 Pack-years = <10 5 NA 2.25E-01
 Pack-years > 10 103 32.2 (18.5-NA)